A careful review of the evidence shows that routine mammography screening leads to overdiagnosis, unnecessary treatment, and net harm. This is one of the most important and most suppressed findings in modern medicine.

The Overdiagnosis Problem

Overdiagnosis occurs when a screening test detects a cancer that would never have caused symptoms or death during the patient's lifetime. These cancers are real — they are true cancers by pathological criteria — but they are harmless. Treating them causes harm without benefit.

The evidence that mammography causes substantial overdiagnosis is now overwhelming:

  • The Nordic Cochrane Centre's review found that for every 2,000 women screened over 10 years, 1 death is prevented and 10 women are unnecessarily treated
  • A 2012 New England Journal of Medicine analysis estimated that mammography causes 1.3 million cases of overdiagnosis over 30 years in the United States
  • The Canadian National Breast Screening Study found no mortality benefit from mammography at 25 years

For every 2,000 women screened over 10 years, 1 death is prevented and 10 women are unnecessarily treated. The harm-to-benefit ratio is 10:1.

The False Positive Problem

Mammography has a high false positive rate. A woman who undergoes annual mammography for 10 years has approximately a 60% chance of receiving at least one false positive result. False positives cause:

  • Anxiety and psychological distress
  • Additional imaging (ultrasound, MRI)
  • Biopsy (with associated complications)
  • Unnecessary surgery in some cases

The Radiation Problem

Mammography uses ionizing radiation, which is itself a cause of breast cancer. The radiation dose from mammography is small, but over a lifetime of screening, it is not negligible. The NCI estimates that mammography causes approximately 1 cancer for every 1,000 women screened annually for 10 years.

What the Evidence Supports

The evidence supports:

  • Breast self-examination (no radiation, no overdiagnosis)
  • Clinical breast examination by a physician
  • Mammography for women with strong family history or BRCA mutations
  • Shared decision-making about screening, with full disclosure of the overdiagnosis risk

The evidence does not support routine annual mammography for all women over 40.